HIGHLIGHTS
- who: -fluorouracil and collaborators from the Department of Psychiatry, Hospital Melaka, Melaka, Department of Oncology, National Cancer Institute have published the research: Review began 08/11/2022 Review ended 08/19/2022 Published 08/22/2022 © Copyright, in the Journal: (JOURNAL) of August/22,/2022
- what: The otorhinolaryngology team should be aware of 5-FU-induced neuropsychiatric symptoms despite their being a rare occurrence.
SUMMARY
5-fluorouracil (5-FU) is an anti-metabolite that is commonly used for breast, colorectal, head and neck, pancreas, and stomach cancers. When present, the commonly . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.